- Efficacy of Hepatic Arterial Infusion Therapy for Advanced Hepatocellular Carcinoma Using 5-Fluorouracil, Epirubicin and Mitomycin-C
-
Hwang JY, Jang BK, Kwon KM, Chung WJ, Park KS, Cho KB, Hwang JS, Ahn SH, Kim GC, Kim YH, Choi JS, Kwon JH
- KMID: 2439746
- Korean J Gastroenterol.
- 2005 Feb;45(2):118-124.
BACKGROUND/AIMS: Prognosis of advanced hepatocellular carcinoma (HCC) treated by conventional therapies has been considered to be poor. The aim of this study was to evaluate the efficacy of hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival improvement with combined radio-chemotherapy in the primary central nervous system lymphomas
-
Wu HG, Kim IH, Ha SW, Park CI, Bang YJ, Huh DS
- KMID: 646026
- J Korean Med Sci.
- 1999 Oct;14(5):565-570.
- doi: 10.3346/jkms.1999.14.5.565
The benefits of radio-chemotherapy in HIV-negative primary central nervous system (CNS) lymphomas were analyzed in 40 patients, who received radiotherapy to the brain or craniospinal axis with the total dose... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination treatment with intrahepatic arterial infusion and intratumoral injection chemotherapy in patients with far-advanced hepatocellular carcinoma and arterioportal or arteriovenous shunts: preliminary results
-
Kim JS, Park YM, Kim NY, Yun HK, Lee KJ, Kim BH, Park SJ, Yeon JW, Jung G
- KMID: 1015571
- Korean J Hepatol.
- 2011 Jun;17(2):120-129.
- doi: 10.3350/kjhep.2011.17.2.120
BACKGROUND/AIMS: Combination treatment consisting of hepatic arterial infusion chemotherapy with epirubicin and cisplatin (HAIC-EC) and systemic infusion of low-dose 5-fluorouracil (5-FU) are sometimes effective against advanced hepatocellular carcinoma (HCC). However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
-
Woo HY, Youn JM, Bae SH, Jang JW, Cha JH, Kim HL, Chun HJ, Choi BG, Choi JY, Yoon SK
- KMID: 1372649
- Korean J Hepatol.
- 2012 Mar;18(1):32-40.
- doi: 10.3350/kjhep.2012.18.1.32
BACKGROUND/AIMS: Low-dose metronomic chemotherapy involves the frequent administration of comparatively low doses of cytotoxic agents with no extended breaks, and it may be as efficient as and less toxic than... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Impacts of Tumor Cell Contamination of Hematopoietic Stem Cell Products in Metastatic Breast Cancer Patients undergoing Autologous Peripheral Blood Stem Cell Transplantation: Multicenter Trial
-
Ahn MJ, Noh YH, Lee YS, Lee YY, Choi IY, Kim IS, Joh EK, Shin DB, Kim SY, Cho KS, Kim HC, Kim HS, Suh CW, Kim SH, Lee JA, Park YS
- KMID: 648253
- J Korean Med Sci.
- 2001 Apr;16(2):175-182.
- doi: 10.3346/jkms.2001.16.2.175
To determine whether the tumor cell contamination of peripheral blood stem cells influences clinical impacts on high-dose chemotherapy in patients with metastatic breast cancer, we analyzed carcinoembryonic antigen (CEA) mRNA... -
- CITED
-
- Close
- SHARE
-
- Close
